← SynDRA
PF-04418948
SynDRA canonical compound SYN0038016 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PTGER2 |
|---|
| Mechanism of action | prostaglandin inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PTGER2 ANTAGONIST
- prostaglandin inhibitor
Cross-references
Synonyms
- PF 04418948
- PF-4418948
- PF04418948
- PF_04418948
- Prostaglandin E2 EP2 subtype antagonist (endometriosis), Pfizer
- I7Z38E70VF
- RefChem:172230
- DTXCID5070783
- UNII-I7Z38E70VF
- LWJGMYMNSNVCEM-UHFFFAOYSA-N
- MFCD24387541
- A1ECS
- C23H20FNO5
- GTPL5817
- orb1304338
- SCHEMBL3632622
- HMS3740A11
- DTB16657
- EX-A1253
- BDBM50403531
- s7211
- AKOS024458362
- CCG-268755
- CS-5011
- EBC-411051
- NCGC00371019-01
- NCGC00371019-02
- NCGC00371019-04
- AC-36273
- AS-56285
- HY-18966
- SY038838
- DS-020217
- NS00073088
- A11882
- PF-04418948?
- BRD-K54871792-001-01-4
- BRD-K54871792-001-02-2
Look up PF-04418948 in the interactive SynDRA portal →